The abstract is read at the publisher; the summary is JClub's.
In Lima, Peru, in-country CSF metagenomic next-generation sequencing detected 20 pathogens in 18 of 43 suspected CNS infection samples (42%), including many missed by routine testing.
- Why it matters: CNS infections in Peru are hard to characterize because many endemic and opportunistic pathogens circulate and specialized neurodiagnostic testing is limited.
- What they did: Adults enrolled at Hospital Nacional Dos de Mayo (Aug 2024–Apr 2025) provided ~0.5–2 mL surplus CSF for in-country DNA/RNA mNGS on a benchtop sequencer with cloud analysis (CZID), with deeper US sequencing validation on a subset.
- The result: mNGS in Peru identified 65% of detected pathogens not found by routine clinical testing, and deeper sequencing produced 3.7-fold (DNA) and 6.9-fold (RNA) more reads, recovering four additional pathogens.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.